Searched for
US BASED MYLAN
FIPB clears Mylan's Rs 4,960-crore FDI proposalForeign Investment Promotion Board (FIPB) cleared FDI proposal of Mylan Laboratories entailing a capital inflow of Rs 4,960 crore.13 Aug, 2015, 10.51 PM IST- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...23 Apr, 2015, 01.59 PM IST
- US drugmaker Mylan to acquire Famy Care for $750 MillionMylan will pay $750 million to buy the women’s health business of Mumbai-based Famy Care and expand its presence in the market for women’s ...03 Feb, 2015, 05.32 AM IST
- Mylan Inc to acquire Famy Care's certain business for $ 800 millionMumbai-based Famy Care is focused on female reproductive health care and is world leader in supplying a wide range of contraceptive pills.02 Feb, 2015, 09.37 PM IST
- Mylan may buy contraceptive co Famy Care for Rs 3,000 croreMylan is said to have pipped private equity bids from Bain Capital and Advent to move closer to a deal. Hong Kong-based AIF Capital holds 1...21 Jan, 2015, 01.33 PM IST
- USFDA warning letter to Agila not to affect acquisition: MylanMylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...17 Sep, 2013, 06.02 PM IST
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...03 Sep, 2013, 08.06 PM IST
- Strides Arcolab surges over 7 pc as FIPB clears Mylan's FDI proposalSince Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.28 Aug, 2013, 02.18 PM IST
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...27 Aug, 2013, 06.29 PM IST
- Mainstay gone, strides in for a rough rideThe company had earlier acquired assets, improved efficiencies and subsequently sold them at attractive valuations.07 Mar, 2013, 04.00 AM IST
- Natco Pharma soars on drug licensing dealNatco Pharma rose as much as 19 per cent after it struck a licensing and supply deal with US-based Mylan for its generic version of multipl...11 Jun, 2008, 11.45 AM IST
- Natco inks agreement with Mylan for CopaxoneHome grown major Natco Pharma today said it has signed a licence and supply agreement with US-based Mylan for the global sale of generic ve...10 Jun, 2008, 08.38 PM IST
- Matrix weighs Docpharma saleHyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.29 Feb, 2008, 12.04 AM IST
- Mylan Labs may use Indian platform for global pharma playWith the acquisition of Merck KGaA’s generic business by Mylan Laboratories, India is set to become a major manufacturing hub for the US dr...14 May, 2007, 12.27 AM IST
- M&As help small pharma cos make it bigConcord Biotech, a small Ahmedabad-based biotechnology firm, on Tuesday shipped its first consignment to its new $1.2bn US-based parent, My...08 Nov, 2006, 01.47 AM IST
- Mylan to span out to Europe, AfricaThe $1.2-bn US-based Mylan Labs may just have captured value across the chain with the Matrix deal.29 Aug, 2006, 02.52 AM IST
- Mylan to buy into MatrixMylan Laboratories’ India foray may be just round the corner - the US company is set to pick up a major stake in Secunderabad-based Matrix ...28 Aug, 2006, 04.18 AM IST
Load More
